CVSI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CVSI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CV Sciences's interest expense for the three months ended in Mar. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CV Sciences's Operating Income for the three months ended in Mar. 2024 was $ -0.62 Mil. CV Sciences's Interest Expense for the three months ended in Mar. 2024 was $ 0.00 Mil. GuruFocus does not calculate CV Sciences's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for CV Sciences's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CV Sciences Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Interest Expense | Get a 7-Day Free Trial | - | -0.01 | -0.14 | -1.54 | - |
CV Sciences Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Interest Expense | Get a 7-Day Free Trial | -0.06 | - | - | - | - |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CV Sciences (OTCPK:CVSI) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
CV Sciences's Interest Expense for the three months ended in Mar. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-0.62 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.02 Mil.
CV Sciences's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
GuruFocus does not calculate CV Sciences's interest coverage with the available data. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. CV Sciences Inc has enough cash to cover all of its debt. Its financial situation is stable.
William Mccorkle | director | 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121 |
Corroon James Michael Jr. | director | 9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126 |
Maroon Joseph C Md | director | 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146 |
Mona Michael Joseph Jr | director | 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146 |
Paul Blake | director | 145 BRANDYWINE PKWY, WEST CHESTER PA 19380 |
Douglas Jesse Mackay | officer: Sr VP Scientific/Regulatory | 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121 |
Joseph D Dowling | officer: Chief Financial Officer | 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146 |
Joerg Grasser | officer: CFO | 2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146 |
Elizabeth Ann Altman | director | 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121 |
Terri F Graham | director | C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123 |
Stephen Martin Schmitz | director | 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146 |
Gary Sligar | director | 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146 |
James A Mcnulty | director | C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146 |
Larry Phillip Raskin | director | 1630 FUNNY CIDE DRIVE, WAXHAW NC 28173 |
Mackay Ventures Inc. | other: Member 10% holding group | 6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118 |
From GuruFocus
By PRNewswire • 12-12-2023
By GuruFocusNews GuruFocusNews • 06-21-2022
By PRNewswire PRNewswire • 03-02-2023
By GuruFocusNews GuruFocusNews • 05-22-2022
By PRNewswire PRNewswire • 03-21-2023
By GuruFocusNews GuruFocusNews • 07-01-2022
By PRNewswire PRNewswire • 03-23-2023
By PRNewswire • 08-01-2023
By PRNewswire PRNewswire • 01-19-2023
By PRNewswire • 09-05-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.